You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Berberine is a new medicine for energy-related metabolic disorders
- In: SUBMITTED ORALS on Wednesday, 16 April 2014, 14:30-15:30
- At: PSWC, Melbourne (Australia) (2014)
- Type: Presentation
- By: JIANG, Jiandong (The Institutes of Pharmaceutical Sciences Chinese Academy of Medical Sciences, Beijing, China)
- Abstract:
Berberine (BBR) is a natural compound isolated from Coptis chinensis and is for decades an over-the-count medicine in China for bacterial-caused diarrhea. We have identified BBR to be an effective drug in treating hyperlipidemia as well as hyperglycemia. Clinical studies showed that oral administration of BBR caused significant reduction of blood..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026